Oncologic outcomes and risk factors for recurrence after tumor-specific mesorectal excision of rectal cancer: 782 Cases

Journal of the Korean Society of Coloproctology

Volumn 28, Issue 2, 2012, Pages 100-107

  Kim, Sam Hee ^a   Bae, Ki Beom ^a   Kim, Jung Min ^a   Shin, Jae Ho ^a   An, Min Sung ^a   Ha, Tae Geun ^a   Ryu, Sung Mok ^a   Kim, Kwang Hee ^a   Kim, Tae Hyeon ^a   Choi, Chang Soo ^a   Shin, Jin Yong ^a   Oh, Minkyung ^b   Baek, Seung Hun ^b   Hong, Kwan Hee ^a  

^a Inje University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Colorectal cancer recurrence; Oncologic outcome; Rectal neoplasms; Tumor specific mesorectal excision

Indexed keywords

ARTICLE; COLORECTAL CANCER;

EID: 84861533317     PISSN: 20937822     EISSN: 20937830     Source Type: Journal    
DOI: 10.3393/jksc.2012.28.2.100     Document Type: Article

References (22)

1. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma: experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 1995;81(3Suppl):60-4.
2. Douglass HO Jr, Moertel CG, Mayer RJ, Thomas PR, Lindblad AS, Mittleman A, et al. Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1986;315:1294-5. (Pubitemid 17049694)
3. Thomas PR, Lindblad AS. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol 1988;13:245-52. (Pubitemid 19009239)
4. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988;80:21-9. (Pubitemid 18076565)
5. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
6. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-82. (Pubitemid 16095660)
7. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
8. Scott N, Jackson P, al-Jaberi T, Dixon MF, Quirke P, Finan PJ. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 1995;82:1031-3.
9. Joh NS, Kim NK, Yun SH, Kim HG, Min JS. Lymph node metastases and tumor deposits in the mesorectum distal to rectal cancer: a need of total mesorectal excision. J Korean Soc Coloproctol 1999;15:273-9.
10. Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg 1997;184:584-8. (Pubitemid 27255217)
11. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg 1982;69:613-6. (Pubitemid 12038080)
12. Arbman G, Nilsson E, Hallbook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996;83:375-9. (Pubitemid 26083175)
13. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 2004;240:260-8. (Pubitemid 38963017)
14. Kim NK, Min BS, Kim JS, Hur H, Lee KY, Sohn SK, et al. Oncologic outcomes and safety after tumor-specific mesorectal excision for resectable rectal cancer: a single institutions experience with 1,276 patients with rectal cancer. J Korean Soc Coloproctol 2008;24:121-33.
15. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
16. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw 2009;7:838-81.
17. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 2004;47:48-58. (Pubitemid 38040245)
18. Law WL, Chu KW. Local recurrence following total mesorectal excision with double-stapling anastomosis for rectal cancers: analysis of risk factors. World J Surg 2002;26:1272-6. (Pubitemid 36920255)
19. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701.
20. Andreoni B, Chiappa A, Bertani E, Bellomi M, Orecchia R, Zampino M, et al. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients. World J Surg Oncol 2007;5:73.
21. Zaheer S, Pemberton JH, Farouk R, Dozois RR, Wolff BG, Ilstrup D. Surgical treatment of adenocarcinoma of the rectum. Ann Surg 1998;227:800-11. (Pubitemid 29119527)
22. Park IJ, Kim HC, Yu CS, Kim JC. Pattern of recurrences and metastases after a curative resection for primary colorectal cancer. J Korean Soc Coloproctol 2008;24:207-13.